1.
|
Phase: Phase III Type: Treatment Status: Completed Age: no age specified Sponsor: Protocol IDs: NPCTG-1700
|
|
2.
|
Phase: Phase III Type: Treatment Status: Closed Age: premenopausal women Sponsor: Protocol IDs: EORTC-10881
|
|
3.
|
Phase: Phase III Type: Treatment Status: Closed Age: 50 to 80 Sponsor: Protocol IDs: EORTC-30843
|
|
4.
|
Phase: Phase III Type: Treatment Status: Closed Age: 80 and under Sponsor: Protocol IDs: EORTC-30891
|
|
5.
|
Phase: Phase III Type: Treatment Status: Closed Age: Under 80 Sponsor: Other Protocol IDs: CDR0000270970, FRE-FNCLCC-GETUG-12/0203, EU-20238, NCT00055731
|
|
6.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-0521, NCT00288080
|
|
7.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-0518, 0518, NCT00329797
|
|
8.
|
Phase: Phase III Type: Treatment Status: Completed Age: Not specified Sponsor: Other Protocol IDs: PR12, CAN-NCIC-PR12, CDR0000589247, NCT00651326
|
|
9.
|
Phase: Phase III Type: Treatment Status: Completed Age: Under 80 Sponsor: NCI, Other Protocol IDs: PR3, CAN-NCIC-PR3, ECOG-JPR03, MRC-PR07, SWOG-JPR3, EU-99013, NCI-T94-0110O, ISRCTN24991896, CDR0000064065, CALGB-9593, T94-0110, NCT00002633
|
|
10.
|
Phase: Phase III Type: Treatment Status: Closed Age: 16 and over Sponsor: NCI, Other Protocol IDs: PR7, CAN-NCIC-PR7, SWOG-JPR7, ICR-CTSU-JPR7, CDR0000066745, JPR7, NCT00003653
|
|
11.
|
Phase: Phase I Type: Treatment Status: Completed Age: Over 18 Sponsor: Other Protocol IDs: I153, CAN-NCIC-IND153, ONCOGENEX-OGX-01-01, CDR0000269888, IND153, NCT00054106
|